Angela Mackay

Title: Angela Mackay: Innovator in Therapeutic Compounds

Introduction

Angela Mackay is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. Her work focuses on creating innovative solutions for viral infections, showcasing her dedication to advancing healthcare.

Latest Patents

Angela Mackay holds a patent for a class of macrocyclic compounds that are useful as inhibitors of viral proteases, specifically targeting the hepatitis C virus (HCV) NS3 protease. The patent outlines the formula of these compounds and details the processes for their synthesis and application in treating or preventing HCV infection. This groundbreaking work has the potential to impact the treatment landscape for those affected by hepatitis C.

Career Highlights

Angela is affiliated with the Istituto di Ricerche di Biologia Molecolare P. Angeletti Spa, where she collaborates with a team of researchers dedicated to exploring innovative biological solutions. Her career is marked by a commitment to research and development in the pharmaceutical industry, contributing to advancements in therapeutic strategies.

Collaborations

Angela has worked alongside notable colleagues, including Immacolata Conte and Joerg Habermann. Their collaborative efforts have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Angela Mackay's contributions to the field of therapeutic compounds exemplify her innovative spirit and commitment to improving healthcare outcomes. Her work continues to inspire future research and development in the fight against viral infections.